-
-
-
7 . Periodical
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
- 저자
- by Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert, et al.
- 소스
- The Lancet Gastroenterology & Hepatology; February 2022, Vol. 7 Issue: 2 p118-127, 10p
-
7 . Periodical
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
- 저자
- by Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu, et al.
- 소스
- The Lancet Gastroenterology & Hepatology; February 2022, Vol. 7 Issue: 2 p128-140, 13p